Advertisement

Topics

Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China

05:04 EST 17 Jan 2019 | Pharmaceutical Business Review

This is the first time that a multinational pharmaceutical company has gained exclusive authorization in China to promote an innovative drug independently developed by a Chinese pharmaceutical company.

The post Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China appeared first on Pharmaceutical Business review.

Original Article: Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China

NEXT ARTICLE

More From BioPortfolio on "Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...